CA2224034C - Mediators useful in an electrochemical biosensor - Google Patents
Mediators useful in an electrochemical biosensor Download PDFInfo
- Publication number
- CA2224034C CA2224034C CA002224034A CA2224034A CA2224034C CA 2224034 C CA2224034 C CA 2224034C CA 002224034 A CA002224034 A CA 002224034A CA 2224034 A CA2224034 A CA 2224034A CA 2224034 C CA2224034 C CA 2224034C
- Authority
- CA
- Canada
- Prior art keywords
- cyano
- methyl
- alkyl
- methoxy
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode
Abstract
Disclosed herein is the use of a variety of diazacyanines as mediators for the electrochemical oxidation of NADH/NADPH to NAD+/NADP+, which are reduced by an oxireductase, also present in the system. By applying the mediator together with NADH/NADPH to the surface of a working electrode, the voltage necessary to achieve the desired oxidation is substantially reduced.
Description
MEDIATORS USEFUL IN AN
ELECTROCHEMICAL BIOSENSOR
Background of the Invention A. Technical Summary:
The present invention relates to an enzyme electrode or an electrochemical biosensor which is suitable for the elec-trochemical determination of the concentration and/or for the survey of one of several components that may be present in a fluid test sample. As an enzyme system, generally every di-hydronicotinamide adenine dinucleotide (NAD) or dihydronicoti-namide adenine dinucleotide phosphate (NADP) dependent system can be considered. These systems combine the selectivity of enzymes with the sensitivity of amperometric detection and are of great interest to the diagnostics industry. The reduction of the nicotinamide co-enzymes (NAD and NADP) is particularly important because they are produced in reactions catalyzed by dehydrogenases. Dehydrogenase catalyzed reactions according to the equation:
Substrate + NAD+(NADP+) Dehydrogenase Product + H+ + NADH(NADPH) play an important role in biological cells and analytical re-actions. Several hundred different dehydrogenases are known which Selectively catalyze the conversion of various sub-strates into products. When the substrate is oxidized, the coenzymes NAD+ and NADP+ are reduced to NADH and NADPH respec-tively. These co-enzymes are a necessary element in the reac-tion due to their ability to act with enzymes to form an en-ergy transferring redox couple.
B. State of the Art:
A variety of reactions relevant to the field of biochemi-cal analysis which use NAD(P) dependent oxireductases are at least in principle capable of being carried out through the use of such enzymes, cf. D. W. Moss et al in N. W. Tietz (Ed.), Textbook of Clinical Chemistry, Pp. 619-763, W. B.
Saunders, Philadelphia, 1986. Generally, the change in the coenzyme, NAD(P)H concentration is determined by optical meth-ods which can cause problems when colored or turbid samples are processed. As an alternative, electrochemical methods, in the form of biosensors, can be used.
It is known that the direct oxidation of NAD(P)H on an electrode surface requires a very high overpotential which leads to undesired phenomena such as electrode fouling or strong interference by contaminating substances. A number of publications and patents published in recent years have dealt with overcoming such problems, partly by the use of mediator molecules. The substances are initially reduced by NAD(P)H
and then oxidatively regenerated in a second step at the an-ode. The use of a mediator facilitates the use of a lower electrochemical potential as compared to direct NAD(P)H oxida-tion. This is illustrated by the following equations:
ELECTROCHEMICAL BIOSENSOR
Background of the Invention A. Technical Summary:
The present invention relates to an enzyme electrode or an electrochemical biosensor which is suitable for the elec-trochemical determination of the concentration and/or for the survey of one of several components that may be present in a fluid test sample. As an enzyme system, generally every di-hydronicotinamide adenine dinucleotide (NAD) or dihydronicoti-namide adenine dinucleotide phosphate (NADP) dependent system can be considered. These systems combine the selectivity of enzymes with the sensitivity of amperometric detection and are of great interest to the diagnostics industry. The reduction of the nicotinamide co-enzymes (NAD and NADP) is particularly important because they are produced in reactions catalyzed by dehydrogenases. Dehydrogenase catalyzed reactions according to the equation:
Substrate + NAD+(NADP+) Dehydrogenase Product + H+ + NADH(NADPH) play an important role in biological cells and analytical re-actions. Several hundred different dehydrogenases are known which Selectively catalyze the conversion of various sub-strates into products. When the substrate is oxidized, the coenzymes NAD+ and NADP+ are reduced to NADH and NADPH respec-tively. These co-enzymes are a necessary element in the reac-tion due to their ability to act with enzymes to form an en-ergy transferring redox couple.
B. State of the Art:
A variety of reactions relevant to the field of biochemi-cal analysis which use NAD(P) dependent oxireductases are at least in principle capable of being carried out through the use of such enzymes, cf. D. W. Moss et al in N. W. Tietz (Ed.), Textbook of Clinical Chemistry, Pp. 619-763, W. B.
Saunders, Philadelphia, 1986. Generally, the change in the coenzyme, NAD(P)H concentration is determined by optical meth-ods which can cause problems when colored or turbid samples are processed. As an alternative, electrochemical methods, in the form of biosensors, can be used.
It is known that the direct oxidation of NAD(P)H on an electrode surface requires a very high overpotential which leads to undesired phenomena such as electrode fouling or strong interference by contaminating substances. A number of publications and patents published in recent years have dealt with overcoming such problems, partly by the use of mediator molecules. The substances are initially reduced by NAD(P)H
and then oxidatively regenerated in a second step at the an-ode. The use of a mediator facilitates the use of a lower electrochemical potential as compared to direct NAD(P)H oxida-tion. This is illustrated by the following equations:
( 1 ) NADH + MediatoroX + > NAD+ + Mediatorrea ( 2 ) Mediatorred > MediatoroX
(anode) Examples for such mediators are often dyestuffs, like methyl-ene blue, Meldola's Blue, Nile Blue, or Toluidine Blue [L.
Gorton, J. Chem. Soc. Faraday Trans. 1, 82 (1986), 1245-1258].
These compounds often have the disadvantage that they them-selves are reoxidized at such a high potential that all the relevant interferences are not always suppressed. In particu-lar, in case of the determination of analytes in blood or urine, is it necessary to avoid the direct oxidation of ascor-bic acid (Vitamin C), acetaminophen, bilirubin, and uric acid.
This makes an oxidation potential in the range of 0 to 150 mV
(versus silver/silver chloride reference) desirable. Further-more, a high chemical turnover rate between NAD(P)H and the mediator as well as between mediator and the anode is desir-able to obtain a sufficiently high current density. This as-pect is crucial in particular for a desired miniaturization of biosensors and is not or only insufficiently covered by previ-ously described mediators. The data of Table 8 herein demon-strate that the present mediator can meet this standard. In the case of a low turnover rate between NAD ( P ) H and mediator, there is observed an increase of the apparent oxidation poten-tial in the presence of substrate. Furthermore, many of the prior art mediators are not sufficiently soluble in aqueous solution thereby necessitating the use of organic solvents and complex coating techniques for applying these mediators to an electrode. This limits the number of useable carrier materi-als for the biosensor, in particular in the field of polymers.
(anode) Examples for such mediators are often dyestuffs, like methyl-ene blue, Meldola's Blue, Nile Blue, or Toluidine Blue [L.
Gorton, J. Chem. Soc. Faraday Trans. 1, 82 (1986), 1245-1258].
These compounds often have the disadvantage that they them-selves are reoxidized at such a high potential that all the relevant interferences are not always suppressed. In particu-lar, in case of the determination of analytes in blood or urine, is it necessary to avoid the direct oxidation of ascor-bic acid (Vitamin C), acetaminophen, bilirubin, and uric acid.
This makes an oxidation potential in the range of 0 to 150 mV
(versus silver/silver chloride reference) desirable. Further-more, a high chemical turnover rate between NAD(P)H and the mediator as well as between mediator and the anode is desir-able to obtain a sufficiently high current density. This as-pect is crucial in particular for a desired miniaturization of biosensors and is not or only insufficiently covered by previ-ously described mediators. The data of Table 8 herein demon-strate that the present mediator can meet this standard. In the case of a low turnover rate between NAD ( P ) H and mediator, there is observed an increase of the apparent oxidation poten-tial in the presence of substrate. Furthermore, many of the prior art mediators are not sufficiently soluble in aqueous solution thereby necessitating the use of organic solvents and complex coating techniques for applying these mediators to an electrode. This limits the number of useable carrier materi-als for the biosensor, in particular in the field of polymers.
Accordingly, it would be desirable and it is an object of the present invention to provide mediators for the electro-catalytic oxidation of NADH or NADPH on carbon electrodes, particularly those produced by screen printing techniques. It is a further object of this invention to provide electrodes bearing the present mediators and NAD(P)H having an oxidation potential where current saturation occurs which is in the range of from 0 to 150 mV as measured against a silver/silver chloride reference electrode with the ability to obtain cur-rent densities on the order of 100 uA/cm2 at 5 mmol/L NAD(P)H.
In addition, it is an object of the present invention to pro-vide mediators which are soluble in aqueous media and which do not inhibit enzymatic activity.
Summary of the Invention The objects of the present invention are met by the use of diazacyanines of Formula I:
R' ~N~
A ~ .H~Z X
N
Referring to Formula I, A represents the remaining mem-bers of an aromatic or quasiaromatic 5 or 6 membered heterocy-clic ring which can optionally be benzanellated;
R1 is alkyl, alkenyl, alkinyl, cycloalkyl or aralkyl;
Z is the residue of a moiety of one of the formulae II, III or IV
R=
/ \ ' ~Rs R~
Rs / i N w R~
Ra , R,o v ,N
R~
In the foregoing formulae:
Rz, R3, R5, R6 and R8 are independently hydrogen, alkyl, alkenyl, cycloalkyl, aralkyl, aryl or a saturated heterocyclic group; or NRzR3 is pyrrolidino, piperidino, morpholino, piperazino or N-alkylpiperazine or N-alkylpiperazino;
R4 and R' are independently hydrogen, alkyl, alkoxy, halo-gen, hydroxy, nitro, cyano, alkanoylamino or alkylsulfony-lamino; or R3 and R4 together are a -CHZCH2- or -CHZCH2CHz- bridge which is optionally substituted with alkyl;
R9 and R1° are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, cyano, alkanoyl or alkylsulfonyl;
m, n and p are independently 0, 1 or 2; and X- is an anion.
In another aspect of the present invention there is provided a method of improving the performance of an electrochemical biosensor which operates with a dehydrogenase catalyst and a co-enzyme as an energy transferring redox couple, which method comprises using an electrode characterized in that it has on its surface a mediator function of Formula l, as defined above, as the working electrode of the biosensor.
Brief Description of the Figures Figure 1 depicts glucose response curves for a buffer solution and for blood obtained using an electrode according to one embodiment of the present invention.
Detailed Description of the Invention Referring to the above formula for the diazacyanines use-ful in the present invention, suitable counteranions (X ) are any organic or inorganic anions which are not themselves re-dox-active in the range of working potentials of the electri-cal biosensor. Exemplary of anions which may be employed are chloride, tetrafluoroborate, hydrogensulfate, sulfate, dihy-drogensulfate, hydrogen phosphate, methylsulfate, ethylsul-fate, acetate, phenylacetate, benzoate, methylsulfonate, ben-zenesulfonate and toluenesulfonate. If the anion used is polyvalent, such as sulfate or hydrogenphosphate, X- is one equivalent of such polyvalent anion.
According to the present invention, preferred diazacya-nines for use as mediators are those in which the heterocycle is represented by the formula:
N
A
and is thiazole, benzothiazole, thiadiazole, pyrazole, inda-zole, imidazole, benzimidazole, triazole, pyridine, quinoline or pyrimidine or is represented by one of the formulae:
Ru i N
N . \
R~~~~ r R" \ S
S
or N-N
Rt~N
S
R'~
where Rl is C1 to C8 alkyl, C3 to CB alkenyl, C3 to CB alkinyl, C4 to C7 cycloalkyl or C~ to C9 aralkyl which are unsubstituted or substituted with fluorine, chlorine, bromine, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano or C1 to C4 alkoxycarbonyl;
R2, R3, R5, R6, R8, R14 and R15 are independently hydrogen, C1 to Ce alkyl, C3 to C8 alkenyl, C4 to C~ cycloalkyl, C, to C9 aralkyl or C6 to Clo aryl which are unsubstituted or substituted with halogen, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano, C1 to C4 alkoxycarbonyl, C1 to C4 alkanoylamino, C1 to C4 alkylsul-fonyl or tetramethysulfonyl;
NRzR3 and NR14R15 are independently pyrrolidino, piperidino or morpholino;
R4 and R' are independently C1 to C8 alkyl; C1 to C8 alkoxy, hy-droxy, fluoro, chloro, bromo, nitro, cyano, C; to C8 alkanoy-lamino or C1 to C8 alkylsulfonylamino;
R3 and R4 together are a -CH2CHz- or -CH2CHZCH2- bridge which is either unsubstituted or substituted with up to 3 methyl groups;
R9 and R1° are independently hydrogen, C1 to Ce alkyl, C1 to Ce alkoxy, hydroxy, f luoro, chloro, bromo, nitro, cyano, C1 to Ce alkanoyl or C1 to CB alkylsulfonyl;
m, n and p are independently 0, 1 or 2;
R11 and R1z are independently hydrogen, C1 to Ce alkyl, C1 to C8 alkoxy, C4 to C~ cycloalkyl, C~ to C9 aralkyl, C6 to C1° aryl, fluoro, chloro, bromo or cyano;
R13 is hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, fluoro, chloro, bromo or cyano; and X- is an anion wherein all of the alkyl, alkenyl, alkoxy and aralkyl groups are either straight chain or branched chain.
Example I
Synthesis of Mediators The preparation of the diazacyanines whose use as NAD(P)H
mediators is the crux of the present invention is disclosed in U.S. 5,208,325 and U.S. 5,436,323 as well as U.S. 4,268,438 and U.S. 4,500,715.
The synthesis is described in detail in U.S. 5,208,325 in columns 5-8, particularly column 5, line 65 to column 6, line 28. In a manner analogous to this synthe-sis, one can use amino heterocycles of the formula:
N
A
NHi diazotize and couple to anilines or indoles of the formulae:
R~
R' i I N.Rs Rs / ~ R~ ~ I
N~ H w ~N ~o R~ R6 ~ ~s R o m R
in the position marked with the arrow followed by quaterniza-tion with compounds of the formula:
where X is a leaving group from which R1 and X in formula I
are derived. This R1X can be, for example, methyl iodide, hy-droxyethyl chloride or dimethyl sulfate. The conditions given in columns 7 and 8 for diazotization and quaternization may also be used.
Example II
Evaluation of Mediators Graphite rod electrodes (3 mm in diameter from Johnson Matthey Electronics, Ward Hill, MA) were prepared by contact-ing the rod with a silver wire, insulating all but the blunt end with heat shrink tubing after which the electrode's sur-face was polished with fine grit sandpaper followed by weigh paper. The electrode was immersed in a 1 mmol/L methanolic solution of the mediator to be tested immersed in 50 mL of phosphate buffer (25 mmol/L, pH 7.0). A cyclic voltammogram was run with 100 mV/sec. from -700 mV to +g00 mV against a saturated calomel reference electrode. The anodic (EoX) and cathodic E~=ed~ peaks were determined. The results obtained us-ing 38 representative compounds of the present invention are set out in Tables 1-6. From the data set out in Tables 1-6 it can be determined that the mediators tested meet the require-ment of having a low oxidation potential to avoid electro-chemical interference, while maintaining some reserve for sys-tem dependent shifts.
I
v COCOt~r1v1 P
aO ~Ot~~ h n1arA1~ V1 h ~
E -~ ~~.~
~
N ~ N
UU UU U V
S .S S
S
U
S. OS ~ Z
r ~ ~z .z Z%~5.~:. Z
Z
i U
S
z ~ a z z S S x'_ Z~j ~ E"r ~
m 0GUS Z
~~2 U ~
~
U T U
U I
a S
U
U
Z
V ~
U U U
U U
O
_ _..U
VU .U ~ U
U
U
T
U
a ~N 1T u'1p f ~
X v a ~.. 011001Y1101N YI fV v1 V1 Vl~~~w~N Hf~ ~f ~ O ,G T O 1~
wIVllrtIwIN Q ~O 11 f~ f~tl IG0 fV r ~D
~ 'fl'Tly T q ~ q ~ ~~ T T T T T Y~ i T'~'~ q q '~ T
~ ~ N ~ O ~ ~' N ~O Ov T 1~1 CO n a ~ f V CD n CC ~ O~ 10 wl.c~-10 - CO aD M ~ a O V ~ s en r, a e~ n r rte, ~, Af tit f~1 f~1 ~ N fV ~ N !V f,1 A1 P1 A1 f~f N fV T IV lY N1 ~ p . . . . . . . ~ . .
5C c O c U U U U U ~ G~ c a U c a U a a U U U V
N U N N N N N N N N
U= ~ ~ ~ ~ U _~ ~ U
x~ ~x OC U U \ / ~ ~ \ / \ / ~ x U U \ I = U \ / ' I ' I .r U~ ~ U ~ ~ U ~ ~ V
k U x U_ Ux O
x x O T ,r x .., x O x x V
x x U U = U = ~ V ~ x x U x U UV UU U~ U N
W
I S r7 _ ~ ~ x'=~=x= x x- x xxxx ~~x x~x x x xx d z ~ ~ E.
y".
x _ ~ x !x x xxxx x~x c~xx x xx _I~U I 'U U _U _ U U U U
= x ,~ x x Z
U~ 1:: U U U ,U v U U U U V x U G U U U U U U U
IU U U U U ~ U U U U
_.: __- = x~ xxl= xx~ x" x~
~~U~U~U~U~U U IU U U U U U U U IU ~U (~ v U U (~ U
'==U _T O
x Z
= x_0! O..= x a ~_ = xx ~ Cr4'.rlN v U IU U U U U S L .:, U 'v U ICi U U U
U U
U ~ U
rv OD Ov O .~ N P1 .? W ~D tv 70 O~ O .-.~ N t~7 T n~. ~O n CO O~
~I r-i 1-i H ..r a1 N -l ri .-H N N N N N N N N N N
a s .rar s .rz s W ~ ! W
a a a ca z H z, Ed.
,z z '~
z 'z,.
~N
~J~~~t/ I Z~K
2~
a \ ~~z.
~ '~ ~
r /
=sz a ~ z a ~' H H iz N
,z w z. z z .
s \ /
Example III
Cyclic Voltammograms of the Mediators To measure the redox potentials, the substances to be tested were dissolved in water at a concentration of 2 m mol/L. On each of a series of screen printed carbon (graphite/carbon black mixture) electrodes (Acheson graphite ink, 3 mmz electrode surface activated by treatment in an oxy-gen plasma), 3 NL of this solution was applied and dried at room temperature. After 10 pL of phosphate buffer (25 m mol/L, pH 7.0) as physiological buffer was added, a cyclic voltammogram was run with 100 mV/sec. against a saturated Ag/AgCl reference electrode. Table 7 sets out the oxidation and reduction potentials which were obtained.
Mediator EoX[mV] Fred[mV]
19 + 29 -477 43 + 92 - 70 From Table 7 it can be determined that the potentials are higher on printed electrodes than on graphite rod electrodes.
Example IV
NADH Oxidation/Titration In the same manner as described for the cyclic voltamme-try experiment, printed graphite electrodes were coated with the particular mediator compound being tested. After connect-ing the treated electrode to a potentiostat, 10 pL of NADH of varying concentration (0, 2, 5 and 10 m mol/L) in phosphate buffer (25 m mol/L, pH ?.0) were added. A working potential was then applied against a saturated Ag/AgCl electrode, and the electrical current measured after 5 seconds. The currents were plotted versus NADH concentration, Table 8 shows the de-termined slopes at different working potentials for different mediators:
Mediator Working Potential [mV] Slope [NA/mM]
17 200 0.060 100 0.15 300 0.36 9 100 0.17 14 100 0.23 300 0.24 27 100 0.31 300 0.36 43 100 0.14 300 0.40 From Table 8 it can be determined that the tested media-tors demonstrate a high current density (0.2 pA/mM corresponds to 100 ~A/cm2 at 3 mm2 electrode surface) .
Example V
Glucose Response Curve (Aqueous and Whole Blood) A printed graphite electrode as used in Example III was coated with 3 pL of the following reagent solutions in which all percentages are w/v:
0.7~ y-Globulin 1.0~ Polyvinyl pyrrolidone 0.1~ Cremophor EL (surfactant) 0.85$ NaCl 15 mmo 1 / 1 NAD+
12 mM Mediator (17) 3.3 Units/pl Glucose dehydrogenase dissolved in 50 mM PIPES buffer, pH 7Ø
After the solution had dried at the electrode, it was connected to a potentiostat whereupon 10 uL of a solution with varying amounts of glucose (0 to 400 mg/dL) in phosphate buffer (25 mmol/L, pH 7.0) or in human blood (45~ hematocrit) were added. The glucose concentration was adjusted by spiking it with a 25~ aqueous solution and determining the actual con-centration with a YSI STAT analyzer. The working potential was applied 15 seconds after applying the sample to a sensor and a current reading was taken after 5 seconds. The obtained currents were plotted against the glucose concentration. Fig.
1 shows the measured response curves for buffer solution and blood. From these response curves, it can be determined that an enzyme electrode made with the present mediators can be 1$
used to determine glucose in aqueous and blood solutions while leaving the enzyme activity intact.
In addition, it is an object of the present invention to pro-vide mediators which are soluble in aqueous media and which do not inhibit enzymatic activity.
Summary of the Invention The objects of the present invention are met by the use of diazacyanines of Formula I:
R' ~N~
A ~ .H~Z X
N
Referring to Formula I, A represents the remaining mem-bers of an aromatic or quasiaromatic 5 or 6 membered heterocy-clic ring which can optionally be benzanellated;
R1 is alkyl, alkenyl, alkinyl, cycloalkyl or aralkyl;
Z is the residue of a moiety of one of the formulae II, III or IV
R=
/ \ ' ~Rs R~
Rs / i N w R~
Ra , R,o v ,N
R~
In the foregoing formulae:
Rz, R3, R5, R6 and R8 are independently hydrogen, alkyl, alkenyl, cycloalkyl, aralkyl, aryl or a saturated heterocyclic group; or NRzR3 is pyrrolidino, piperidino, morpholino, piperazino or N-alkylpiperazine or N-alkylpiperazino;
R4 and R' are independently hydrogen, alkyl, alkoxy, halo-gen, hydroxy, nitro, cyano, alkanoylamino or alkylsulfony-lamino; or R3 and R4 together are a -CHZCH2- or -CHZCH2CHz- bridge which is optionally substituted with alkyl;
R9 and R1° are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, cyano, alkanoyl or alkylsulfonyl;
m, n and p are independently 0, 1 or 2; and X- is an anion.
In another aspect of the present invention there is provided a method of improving the performance of an electrochemical biosensor which operates with a dehydrogenase catalyst and a co-enzyme as an energy transferring redox couple, which method comprises using an electrode characterized in that it has on its surface a mediator function of Formula l, as defined above, as the working electrode of the biosensor.
Brief Description of the Figures Figure 1 depicts glucose response curves for a buffer solution and for blood obtained using an electrode according to one embodiment of the present invention.
Detailed Description of the Invention Referring to the above formula for the diazacyanines use-ful in the present invention, suitable counteranions (X ) are any organic or inorganic anions which are not themselves re-dox-active in the range of working potentials of the electri-cal biosensor. Exemplary of anions which may be employed are chloride, tetrafluoroborate, hydrogensulfate, sulfate, dihy-drogensulfate, hydrogen phosphate, methylsulfate, ethylsul-fate, acetate, phenylacetate, benzoate, methylsulfonate, ben-zenesulfonate and toluenesulfonate. If the anion used is polyvalent, such as sulfate or hydrogenphosphate, X- is one equivalent of such polyvalent anion.
According to the present invention, preferred diazacya-nines for use as mediators are those in which the heterocycle is represented by the formula:
N
A
and is thiazole, benzothiazole, thiadiazole, pyrazole, inda-zole, imidazole, benzimidazole, triazole, pyridine, quinoline or pyrimidine or is represented by one of the formulae:
Ru i N
N . \
R~~~~ r R" \ S
S
or N-N
Rt~N
S
R'~
where Rl is C1 to C8 alkyl, C3 to CB alkenyl, C3 to CB alkinyl, C4 to C7 cycloalkyl or C~ to C9 aralkyl which are unsubstituted or substituted with fluorine, chlorine, bromine, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano or C1 to C4 alkoxycarbonyl;
R2, R3, R5, R6, R8, R14 and R15 are independently hydrogen, C1 to Ce alkyl, C3 to C8 alkenyl, C4 to C~ cycloalkyl, C, to C9 aralkyl or C6 to Clo aryl which are unsubstituted or substituted with halogen, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano, C1 to C4 alkoxycarbonyl, C1 to C4 alkanoylamino, C1 to C4 alkylsul-fonyl or tetramethysulfonyl;
NRzR3 and NR14R15 are independently pyrrolidino, piperidino or morpholino;
R4 and R' are independently C1 to C8 alkyl; C1 to C8 alkoxy, hy-droxy, fluoro, chloro, bromo, nitro, cyano, C; to C8 alkanoy-lamino or C1 to C8 alkylsulfonylamino;
R3 and R4 together are a -CH2CHz- or -CH2CHZCH2- bridge which is either unsubstituted or substituted with up to 3 methyl groups;
R9 and R1° are independently hydrogen, C1 to Ce alkyl, C1 to Ce alkoxy, hydroxy, f luoro, chloro, bromo, nitro, cyano, C1 to Ce alkanoyl or C1 to CB alkylsulfonyl;
m, n and p are independently 0, 1 or 2;
R11 and R1z are independently hydrogen, C1 to Ce alkyl, C1 to C8 alkoxy, C4 to C~ cycloalkyl, C~ to C9 aralkyl, C6 to C1° aryl, fluoro, chloro, bromo or cyano;
R13 is hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, fluoro, chloro, bromo or cyano; and X- is an anion wherein all of the alkyl, alkenyl, alkoxy and aralkyl groups are either straight chain or branched chain.
Example I
Synthesis of Mediators The preparation of the diazacyanines whose use as NAD(P)H
mediators is the crux of the present invention is disclosed in U.S. 5,208,325 and U.S. 5,436,323 as well as U.S. 4,268,438 and U.S. 4,500,715.
The synthesis is described in detail in U.S. 5,208,325 in columns 5-8, particularly column 5, line 65 to column 6, line 28. In a manner analogous to this synthe-sis, one can use amino heterocycles of the formula:
N
A
NHi diazotize and couple to anilines or indoles of the formulae:
R~
R' i I N.Rs Rs / ~ R~ ~ I
N~ H w ~N ~o R~ R6 ~ ~s R o m R
in the position marked with the arrow followed by quaterniza-tion with compounds of the formula:
where X is a leaving group from which R1 and X in formula I
are derived. This R1X can be, for example, methyl iodide, hy-droxyethyl chloride or dimethyl sulfate. The conditions given in columns 7 and 8 for diazotization and quaternization may also be used.
Example II
Evaluation of Mediators Graphite rod electrodes (3 mm in diameter from Johnson Matthey Electronics, Ward Hill, MA) were prepared by contact-ing the rod with a silver wire, insulating all but the blunt end with heat shrink tubing after which the electrode's sur-face was polished with fine grit sandpaper followed by weigh paper. The electrode was immersed in a 1 mmol/L methanolic solution of the mediator to be tested immersed in 50 mL of phosphate buffer (25 mmol/L, pH 7.0). A cyclic voltammogram was run with 100 mV/sec. from -700 mV to +g00 mV against a saturated calomel reference electrode. The anodic (EoX) and cathodic E~=ed~ peaks were determined. The results obtained us-ing 38 representative compounds of the present invention are set out in Tables 1-6. From the data set out in Tables 1-6 it can be determined that the mediators tested meet the require-ment of having a low oxidation potential to avoid electro-chemical interference, while maintaining some reserve for sys-tem dependent shifts.
I
v COCOt~r1v1 P
aO ~Ot~~ h n1arA1~ V1 h ~
E -~ ~~.~
~
N ~ N
UU UU U V
S .S S
S
U
S. OS ~ Z
r ~ ~z .z Z%~5.~:. Z
Z
i U
S
z ~ a z z S S x'_ Z~j ~ E"r ~
m 0GUS Z
~~2 U ~
~
U T U
U I
a S
U
U
Z
V ~
U U U
U U
O
_ _..U
VU .U ~ U
U
U
T
U
a ~N 1T u'1p f ~
X v a ~.. 011001Y1101N YI fV v1 V1 Vl~~~w~N Hf~ ~f ~ O ,G T O 1~
wIVllrtIwIN Q ~O 11 f~ f~tl IG0 fV r ~D
~ 'fl'Tly T q ~ q ~ ~~ T T T T T Y~ i T'~'~ q q '~ T
~ ~ N ~ O ~ ~' N ~O Ov T 1~1 CO n a ~ f V CD n CC ~ O~ 10 wl.c~-10 - CO aD M ~ a O V ~ s en r, a e~ n r rte, ~, Af tit f~1 f~1 ~ N fV ~ N !V f,1 A1 P1 A1 f~f N fV T IV lY N1 ~ p . . . . . . . ~ . .
5C c O c U U U U U ~ G~ c a U c a U a a U U U V
N U N N N N N N N N
U= ~ ~ ~ ~ U _~ ~ U
x~ ~x OC U U \ / ~ ~ \ / \ / ~ x U U \ I = U \ / ' I ' I .r U~ ~ U ~ ~ U ~ ~ V
k U x U_ Ux O
x x O T ,r x .., x O x x V
x x U U = U = ~ V ~ x x U x U UV UU U~ U N
W
I S r7 _ ~ ~ x'=~=x= x x- x xxxx ~~x x~x x x xx d z ~ ~ E.
y".
x _ ~ x !x x xxxx x~x c~xx x xx _I~U I 'U U _U _ U U U U
= x ,~ x x Z
U~ 1:: U U U ,U v U U U U V x U G U U U U U U U
IU U U U U ~ U U U U
_.: __- = x~ xxl= xx~ x" x~
~~U~U~U~U~U U IU U U U U U U U IU ~U (~ v U U (~ U
'==U _T O
x Z
= x_0! O..= x a ~_ = xx ~ Cr4'.rlN v U IU U U U U S L .:, U 'v U ICi U U U
U U
U ~ U
rv OD Ov O .~ N P1 .? W ~D tv 70 O~ O .-.~ N t~7 T n~. ~O n CO O~
~I r-i 1-i H ..r a1 N -l ri .-H N N N N N N N N N N
a s .rar s .rz s W ~ ! W
a a a ca z H z, Ed.
,z z '~
z 'z,.
~N
~J~~~t/ I Z~K
2~
a \ ~~z.
~ '~ ~
r /
=sz a ~ z a ~' H H iz N
,z w z. z z .
s \ /
Example III
Cyclic Voltammograms of the Mediators To measure the redox potentials, the substances to be tested were dissolved in water at a concentration of 2 m mol/L. On each of a series of screen printed carbon (graphite/carbon black mixture) electrodes (Acheson graphite ink, 3 mmz electrode surface activated by treatment in an oxy-gen plasma), 3 NL of this solution was applied and dried at room temperature. After 10 pL of phosphate buffer (25 m mol/L, pH 7.0) as physiological buffer was added, a cyclic voltammogram was run with 100 mV/sec. against a saturated Ag/AgCl reference electrode. Table 7 sets out the oxidation and reduction potentials which were obtained.
Mediator EoX[mV] Fred[mV]
19 + 29 -477 43 + 92 - 70 From Table 7 it can be determined that the potentials are higher on printed electrodes than on graphite rod electrodes.
Example IV
NADH Oxidation/Titration In the same manner as described for the cyclic voltamme-try experiment, printed graphite electrodes were coated with the particular mediator compound being tested. After connect-ing the treated electrode to a potentiostat, 10 pL of NADH of varying concentration (0, 2, 5 and 10 m mol/L) in phosphate buffer (25 m mol/L, pH ?.0) were added. A working potential was then applied against a saturated Ag/AgCl electrode, and the electrical current measured after 5 seconds. The currents were plotted versus NADH concentration, Table 8 shows the de-termined slopes at different working potentials for different mediators:
Mediator Working Potential [mV] Slope [NA/mM]
17 200 0.060 100 0.15 300 0.36 9 100 0.17 14 100 0.23 300 0.24 27 100 0.31 300 0.36 43 100 0.14 300 0.40 From Table 8 it can be determined that the tested media-tors demonstrate a high current density (0.2 pA/mM corresponds to 100 ~A/cm2 at 3 mm2 electrode surface) .
Example V
Glucose Response Curve (Aqueous and Whole Blood) A printed graphite electrode as used in Example III was coated with 3 pL of the following reagent solutions in which all percentages are w/v:
0.7~ y-Globulin 1.0~ Polyvinyl pyrrolidone 0.1~ Cremophor EL (surfactant) 0.85$ NaCl 15 mmo 1 / 1 NAD+
12 mM Mediator (17) 3.3 Units/pl Glucose dehydrogenase dissolved in 50 mM PIPES buffer, pH 7Ø
After the solution had dried at the electrode, it was connected to a potentiostat whereupon 10 uL of a solution with varying amounts of glucose (0 to 400 mg/dL) in phosphate buffer (25 mmol/L, pH 7.0) or in human blood (45~ hematocrit) were added. The glucose concentration was adjusted by spiking it with a 25~ aqueous solution and determining the actual con-centration with a YSI STAT analyzer. The working potential was applied 15 seconds after applying the sample to a sensor and a current reading was taken after 5 seconds. The obtained currents were plotted against the glucose concentration. Fig.
1 shows the measured response curves for buffer solution and blood. From these response curves, it can be determined that an enzyme electrode made with the present mediators can be 1$
used to determine glucose in aqueous and blood solutions while leaving the enzyme activity intact.
Claims (10)
1. An electrode suitable for electrochemical regeneration of dihydronicotinamide adenine dinucleotide (NADH), dihydronicotinamide adenine dinucleotide phosphate (NADPH) or analogs thereof characterized in that it has on its surface a mediator function of Formula I:
in which:
A represents the remaining members of an aromatic or quasiaromatic or 6 membered heterocyclic ring which can optionally be benzanellated;
R1 is alkyl, alkenyl, alkinyl, cycloalkyl or aralkyl;
Z is the residue of a moiety of one of the formulae II, III or IV
wherein:
R2, R3, R5, R6 and R8 are independently hydrogen, alkyl, alkenyl, cycloalkyl, aralkyl, aryl or a saturated heterocyclic group;
NR2R3 is pyrrolidino, piperidino, morpholino, piperazino or N-alkylpiperazine or N-alkylpiperazino;
R4 and R7 are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, cyano, alkanoylamino or alkylsulfonylamino;
R3 and R4 together are a -CH2CH2- or -CH2CH2CH2- bridge which is optionally substituted with alkyl;
R9 and R10 are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, vitro, cyano, alkanoyl or alkylsulfonyl;
m, n and p are independently 0, 1 or 2; and X is an anion.
in which:
A represents the remaining members of an aromatic or quasiaromatic or 6 membered heterocyclic ring which can optionally be benzanellated;
R1 is alkyl, alkenyl, alkinyl, cycloalkyl or aralkyl;
Z is the residue of a moiety of one of the formulae II, III or IV
wherein:
R2, R3, R5, R6 and R8 are independently hydrogen, alkyl, alkenyl, cycloalkyl, aralkyl, aryl or a saturated heterocyclic group;
NR2R3 is pyrrolidino, piperidino, morpholino, piperazino or N-alkylpiperazine or N-alkylpiperazino;
R4 and R7 are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, cyano, alkanoylamino or alkylsulfonylamino;
R3 and R4 together are a -CH2CH2- or -CH2CH2CH2- bridge which is optionally substituted with alkyl;
R9 and R10 are independently hydrogen, alkyl, alkoxy, halogen, hydroxy, vitro, cyano, alkanoyl or alkylsulfonyl;
m, n and p are independently 0, 1 or 2; and X is an anion.
2. The electrode of Claim 1 in which is thiazole, benzothiazole, thiadiazole, pyrazole, indazole, imidazole, benzimidazole, triazole, pyridine, quinoline or pyrimidine.
3. The electrode of Claim 1 wherein the mediator is a cationic dyestuff of Formula I in which the heterocycle:
R1 is C1 to C8 alkyl, C3 to C8 alkenyl, C3 to C8 alkinyl, C4 to C7 cycloalkyl or C7 to C9 aralkyl which are unsubstituted or sub-stituted with fluorine, chlorine, bromine, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano or C1 to C4 alkoxycarbonyl;
R2, R3, R5, R6, R8, R14 and R15 are independently hydrogen, C1 to C8 alkyl, C3 to C8 alkenyl, C4 to C7 cycloalkyl, C7 to C9 aralkyl or C6 to C10 aryl which are unsubstituted or substituted with halogen, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano, C1 to C4 alkoxycarbonyl, C1 to C4 alkanoylamino, C1 to C4 alkylsulfonyl or tetramethylsulfonyl;
NR2R3 and NR14R15 are independently pyrrolidino, piperidino or morpholino;
R4 and R7 are independently C1 to C8 alkyl; C1 to C8 alkoxy, hydroxy, fluoro, chloro, bromo, nitro, cyano, C1 to C8 alkanoylamino or C1 to C8 alkylsulfonylamino;
R3 and R4 together are a -CH2CH2- or -CH2CH2CH2- bridge which is either unsubstituted or substituted with up to 3 methyl groups;
R9 and R10 are independently hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, hydroxy, fluoro, chloro, bromo, nitro, cyano, C1 to C8 alkanoyl or C1 to C8 alkylsulfonyl;
m, n and p are independently 0, 1 or 2;
R11 and R12 are independently hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, C4 to C7 cycloalkyl, C7 to C9 aralkyl, C6 to C10 aryl, fluoro, chloro, bromo or cyano;
R13 is hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, fluoro, chloro, bromo or cyano; and X is an anion wherein all of the alkyl, alkenyl, alkoxy and aralkyl groups are either straight chain or branched chain.
R1 is C1 to C8 alkyl, C3 to C8 alkenyl, C3 to C8 alkinyl, C4 to C7 cycloalkyl or C7 to C9 aralkyl which are unsubstituted or sub-stituted with fluorine, chlorine, bromine, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano or C1 to C4 alkoxycarbonyl;
R2, R3, R5, R6, R8, R14 and R15 are independently hydrogen, C1 to C8 alkyl, C3 to C8 alkenyl, C4 to C7 cycloalkyl, C7 to C9 aralkyl or C6 to C10 aryl which are unsubstituted or substituted with halogen, hydroxy, C1 to C4 alkyl, C1 to C4 alkoxy, cyano, C1 to C4 alkoxycarbonyl, C1 to C4 alkanoylamino, C1 to C4 alkylsulfonyl or tetramethylsulfonyl;
NR2R3 and NR14R15 are independently pyrrolidino, piperidino or morpholino;
R4 and R7 are independently C1 to C8 alkyl; C1 to C8 alkoxy, hydroxy, fluoro, chloro, bromo, nitro, cyano, C1 to C8 alkanoylamino or C1 to C8 alkylsulfonylamino;
R3 and R4 together are a -CH2CH2- or -CH2CH2CH2- bridge which is either unsubstituted or substituted with up to 3 methyl groups;
R9 and R10 are independently hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, hydroxy, fluoro, chloro, bromo, nitro, cyano, C1 to C8 alkanoyl or C1 to C8 alkylsulfonyl;
m, n and p are independently 0, 1 or 2;
R11 and R12 are independently hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, C4 to C7 cycloalkyl, C7 to C9 aralkyl, C6 to C10 aryl, fluoro, chloro, bromo or cyano;
R13 is hydrogen, C1 to C8 alkyl, C1 to C8 alkoxy, fluoro, chloro, bromo or cyano; and X is an anion wherein all of the alkyl, alkenyl, alkoxy and aralkyl groups are either straight chain or branched chain.
4. The electrode of Claim 1 in which the mediator is characterized by the formula:
in which R1 means C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched;
R2, R3, R14 and R15 independently of one another mean C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, nitro, acetyl, methylsulfonyl or acetylamino, and R2 and R14 independently of one another may mean in addition hydrogen or NR2R3 and NR14R15 independently of one another mean pyrrolidino, piperidino or morpholino, R4a means hydrogen, fluoro, chloro, methyl or methoxy, R4b means hydrogen, fluoro, chloro, methyl, methoxy, cyano, ni-tro, hydroxy, acetylamino, propionylamino or methylsulfony-lamino and X- means an anion.
in which R1 means C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched;
R2, R3, R14 and R15 independently of one another mean C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, nitro, acetyl, methylsulfonyl or acetylamino, and R2 and R14 independently of one another may mean in addition hydrogen or NR2R3 and NR14R15 independently of one another mean pyrrolidino, piperidino or morpholino, R4a means hydrogen, fluoro, chloro, methyl or methoxy, R4b means hydrogen, fluoro, chloro, methyl, methoxy, cyano, ni-tro, hydroxy, acetylamino, propionylamino or methylsulfony-lamino and X- means an anion.
5. The electrode of Claim 4 wherein:
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R2, R3, R14 and R15 independently of one another mean methyl, ethyl, propyl, hydroxyethyl, hydroxypropyl, cyanoethyl, ben-zyl, cyclohexyl, phenyl, methylphenyl, methoxyphenyl, cya-nophenyl or tetramethylensulfon-3-yl and R14 additionally means hydrogen or NR2R3 and NR14R15 independently of one another mean pyrrolidino, piperidino or morpholino, R4a means hydrogen, methyl or methoxy, R4b means hydrogen, chloro, methyl, methoxy, cyano, acetylamino or methylsulfonylamino and X- means an anion.
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R2, R3, R14 and R15 independently of one another mean methyl, ethyl, propyl, hydroxyethyl, hydroxypropyl, cyanoethyl, ben-zyl, cyclohexyl, phenyl, methylphenyl, methoxyphenyl, cya-nophenyl or tetramethylensulfon-3-yl and R14 additionally means hydrogen or NR2R3 and NR14R15 independently of one another mean pyrrolidino, piperidino or morpholino, R4a means hydrogen, methyl or methoxy, R4b means hydrogen, chloro, methyl, methoxy, cyano, acetylamino or methylsulfonylamino and X- means an anion.
6. The electrode of Claim 1 wherein the mediator is charac-terized by the formula:
wherein:
R1 means C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, R2 and R3 independently of one another mean C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cy-clopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, ni-tro, acetyl, methylsulfonyl or acetylamino, and R2 may mean in addition hydrogen or NR2R3 means pyrrolidino, piperidino or morpholino, R4a means hydrogen, fluorine, chlorine, methyl or methoxy, R4b means hydrogen, fluorine, chlorine, methyl, methoxy, cyano, nitro, hydroxy, acetylamino, propionylamino or methylsulfony-lamino, R13 means hydrogen, fluorine, chlorine, methyl, methoxy or ethoxy and X- means an anion.
wherein:
R1 means C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, R2 and R3 independently of one another mean C1- to C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cy-clopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, ni-tro, acetyl, methylsulfonyl or acetylamino, and R2 may mean in addition hydrogen or NR2R3 means pyrrolidino, piperidino or morpholino, R4a means hydrogen, fluorine, chlorine, methyl or methoxy, R4b means hydrogen, fluorine, chlorine, methyl, methoxy, cyano, nitro, hydroxy, acetylamino, propionylamino or methylsulfony-lamino, R13 means hydrogen, fluorine, chlorine, methyl, methoxy or ethoxy and X- means an anion.
7. The electrode of Claim 6 wherein:
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R2 and R3 independently of one another mean methyl, ethyl, pro-pyl, hydroxyethyl, hydroxypropyl, cyanoethyl, benzyl, cyclo-hexyl, phenyl, methylphenyl, methoxyphenyl, cyanophenyl or te-tramethylensulfon-3-yl or NR2R3 means pyrrolidino, piperidino or morpholino, R4a means hydrogen, methyl or methoxy, R4b means hydrogen, chlorine, methyl, methoxy, cyano, acety-lamino or methylsulfonylamino, R13 means hydrogen or methoxy and X- means an anion.
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R2 and R3 independently of one another mean methyl, ethyl, pro-pyl, hydroxyethyl, hydroxypropyl, cyanoethyl, benzyl, cyclo-hexyl, phenyl, methylphenyl, methoxyphenyl, cyanophenyl or te-tramethylensulfon-3-yl or NR2R3 means pyrrolidino, piperidino or morpholino, R4a means hydrogen, methyl or methoxy, R4b means hydrogen, chlorine, methyl, methoxy, cyano, acety-lamino or methylsulfonylamino, R13 means hydrogen or methoxy and X- means an anion.
8. The electrode of Claim 1 wherein the mediator is charac-terized by the formula:
in which R1 means C1-C4-alkyl, which is optionally unsubstituted or sub-stituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, R8 means C1-C4-alkyl, which is optionally unsubstituted or sub-stituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl or phenyl, R9 and R10 independently mean hydrogen, fluorine, chlorine, methyl, methoxy, cyano, nitro, acetyl or methylsulfonyl, R14 and R15 independently mean C1-C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsub-stituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, nitro, acetyl, methyl-sulfonyl or acetylamino, R14 may mean in addition hydrogen, NR14R15 means pyrrolidino, piperidino or morpholino and X- means an anion.
in which R1 means C1-C4-alkyl, which is optionally unsubstituted or sub-stituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, R8 means C1-C4-alkyl, which is optionally unsubstituted or sub-stituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl or phenyl, R9 and R10 independently mean hydrogen, fluorine, chlorine, methyl, methoxy, cyano, nitro, acetyl or methylsulfonyl, R14 and R15 independently mean C1-C4-alkyl, which is optionally unsubstituted or substituted by fluorine, chlorine, hydroxy, methoxy, ethoxy, cyano, methoxycarbonyl or phenyl and which is optionally branched or unbranched, cyclopentyl, cyclohexyl, tetramethylensulfon-3-yl or phenyl, which is optionally unsub-stituted or substituted by fluorine, chlorine, hydroxy, methyl, ethyl, methoxy, ethoxy, cyano, nitro, acetyl, methyl-sulfonyl or acetylamino, R14 may mean in addition hydrogen, NR14R15 means pyrrolidino, piperidino or morpholino and X- means an anion.
9. The electrode of Claim 8 wherein:
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R8 means methyl, ethyl, hydroxyethyl, cyanoethyl or benzyl, R9 means cyano, nitro, acetyl or methylsulfonyl, R10 means hydrogen, chlorine, methyl or cyano, R14 and R15 independently of one another mean methyl, ethyl, propyl, hydroxyethyl, hydroxypropyl, cyanoethyl, benzyl, cy-clohexyl, phenyl, methylphenyl, methoxyphenyl, cyanophenyl or tetramethylensulfon-3-yl and R14 additionally means hydrogen or NR14R15 means pyrrolidino, piperidino or morpholino and X- means an anion.
R1 means methyl, ethyl, hydroxyethyl, methoxyethyl, cyanoethyl or benzyl, R8 means methyl, ethyl, hydroxyethyl, cyanoethyl or benzyl, R9 means cyano, nitro, acetyl or methylsulfonyl, R10 means hydrogen, chlorine, methyl or cyano, R14 and R15 independently of one another mean methyl, ethyl, propyl, hydroxyethyl, hydroxypropyl, cyanoethyl, benzyl, cy-clohexyl, phenyl, methylphenyl, methoxyphenyl, cyanophenyl or tetramethylensulfon-3-yl and R14 additionally means hydrogen or NR14R15 means pyrrolidino, piperidino or morpholino and X- means an anion.
10. A method of improving the performance of an electro-chemical biosensor having a working and counter/reference electrode which operates with a dehydrogenase catalyst and a co-enzyme as an energy transferring redox couple, which method comprises using the electrode described in Claim 1 as the working electrode of the biosensor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/762,098 US5866353A (en) | 1996-12-09 | 1996-12-09 | Electro chemical biosensor containing diazacyanine mediator for co-enzyme regeneration |
| US08/762,098 | 1996-12-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2224034A1 CA2224034A1 (en) | 1998-06-09 |
| CA2224034C true CA2224034C (en) | 2004-02-17 |
Family
ID=25064127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002224034A Expired - Fee Related CA2224034C (en) | 1996-12-09 | 1997-12-08 | Mediators useful in an electrochemical biosensor |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5866353A (en) |
| EP (1) | EP0846948B1 (en) |
| JP (1) | JP3966591B2 (en) |
| AT (1) | ATE262174T1 (en) |
| AU (1) | AU726868B2 (en) |
| CA (1) | CA2224034C (en) |
| DE (1) | DE69728115T2 (en) |
| DK (1) | DK0846948T3 (en) |
| ES (1) | ES2216096T3 (en) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6500571B2 (en) | 1998-08-19 | 2002-12-31 | Powerzyme, Inc. | Enzymatic fuel cell |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| EP1404232B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Blood sampling apparatus and method |
| AU2002348683A1 (en) * | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| WO2002100460A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Electric lancet actuator |
| US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
| US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| ES2357887T3 (en) | 2001-06-12 | 2011-05-03 | Pelikan Technologies Inc. | APPARATUS FOR IMPROVING THE BLOOD OBTAINING SUCCESS RATE FROM A CAPILLARY PUNCTURE. |
| US6787013B2 (en) * | 2001-09-10 | 2004-09-07 | Eumed Biotechnology Co., Ltd. | Biosensor |
| FR2829926B1 (en) * | 2001-09-26 | 2004-10-01 | Oreal | COMPOSITION FOR DYEING KERATINIC FIBERS COMPRISING A SPECIAL DICATION DIAZOIC DYE |
| GB0204232D0 (en) * | 2002-02-22 | 2002-04-10 | Isis Innovation | Assay |
| US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US8784335B2 (en) * | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7648468B2 (en) * | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9795334B2 (en) * | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7331931B2 (en) * | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7265881B2 (en) * | 2002-12-20 | 2007-09-04 | Hewlett-Packard Development Company, L.P. | Method and apparatus for measuring assembly and alignment errors in sensor assemblies |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
| US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| CA2448618A1 (en) * | 2003-09-11 | 2005-03-11 | Amer Hammami | New 2,2'-azino-bis-thiazolines as precursors to air-stable radicals |
| WO2005033659A2 (en) | 2003-09-29 | 2005-04-14 | Pelikan Technologies, Inc. | Method and apparatus for an improved sample capture device |
| US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
| US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
| EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
| US9775553B2 (en) * | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| MX2007004331A (en) * | 2004-10-12 | 2007-06-05 | Bayer Healthcare Llc | Concentration determination in a diffusion barrier layer. |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| EP2254458A1 (en) | 2008-02-04 | 2010-12-01 | Bayer HealthCare, LLC | Semiconductor based analyte sensors and methods |
| US8008037B2 (en) | 2008-03-27 | 2011-08-30 | Roche Diagnostics Operations, Inc. | Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline |
| US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
| CA2735670A1 (en) | 2008-09-19 | 2010-03-25 | Swetha Chinnayelka | Analyte sensors, systems, testing apparatus and manufacturing methods |
| CN102171557B (en) * | 2008-09-19 | 2016-10-19 | 安晟信医疗科技控股公司 | There is electrochemical appliance and the manufacture method thereof of the electro-chemical activity of enhancing |
| US8551400B2 (en) * | 2008-09-19 | 2013-10-08 | Bayer Healthcare Llc | Analyte sensors, testing apparatus and manufacturing methods |
| CN102202575A (en) * | 2008-09-19 | 2011-09-28 | 拜尔健康护理有限责任公司 | Lancet analyte sensors and methods of manufacturing |
| US20100187132A1 (en) * | 2008-12-29 | 2010-07-29 | Don Alden | Determination of the real electrochemical surface areas of screen printed electrodes |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| WO2011024487A1 (en) * | 2009-08-31 | 2011-03-03 | パナソニック株式会社 | Sensor and concentration measurement method |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| TWI476402B (en) | 2012-08-10 | 2015-03-11 | Univ Ishou | Sensing method of electrochemical sensor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982003729A1 (en) * | 1981-04-08 | 1982-10-28 | Lo Gorton | Electrode for the electrochemical regeneration of co-enzyme,a method of making said electrode,and the use thereof |
| GB8424709D0 (en) * | 1984-10-01 | 1984-11-07 | Minnesota Mining & Mfg | Azine redox dyes and leuco azine dyes |
| DE4100810A1 (en) * | 1991-01-12 | 1992-07-16 | Bayer Ag | CATIONIC 1,3,4-THIADIAZOLE DYES |
| DE4222257A1 (en) * | 1992-07-07 | 1994-01-13 | Bayer Ag | Cationic thiadiazole diphenylamine dyes |
| US5393615A (en) * | 1994-02-03 | 1995-02-28 | Miles Inc. | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof |
| US5498542A (en) * | 1994-09-29 | 1996-03-12 | Bayer Corporation | Electrode mediators for regeneration of NADH and NADPH |
| DE4442253A1 (en) * | 1994-11-28 | 1996-05-30 | Bayer Corp N D Ges D Staates I | Electrochemical enzyme biosensor |
| US5520786A (en) * | 1995-06-06 | 1996-05-28 | Bayer Corporation | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof |
-
1996
- 1996-12-09 US US08/762,098 patent/US5866353A/en not_active Expired - Lifetime
-
1997
- 1997-11-26 EP EP97120715A patent/EP0846948B1/en not_active Expired - Lifetime
- 1997-11-26 ES ES97120715T patent/ES2216096T3/en not_active Expired - Lifetime
- 1997-11-26 AT AT97120715T patent/ATE262174T1/en not_active IP Right Cessation
- 1997-11-26 DE DE69728115T patent/DE69728115T2/en not_active Expired - Lifetime
- 1997-11-26 DK DK97120715T patent/DK0846948T3/en active
- 1997-12-08 AU AU47602/97A patent/AU726868B2/en not_active Ceased
- 1997-12-08 JP JP33622197A patent/JP3966591B2/en not_active Expired - Fee Related
- 1997-12-08 CA CA002224034A patent/CA2224034C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5866353A (en) | 1999-02-02 |
| EP0846948B1 (en) | 2004-03-17 |
| CA2224034A1 (en) | 1998-06-09 |
| DE69728115D1 (en) | 2004-04-22 |
| EP0846948A1 (en) | 1998-06-10 |
| ATE262174T1 (en) | 2004-04-15 |
| JP3966591B2 (en) | 2007-08-29 |
| ES2216096T3 (en) | 2004-10-16 |
| DK0846948T3 (en) | 2004-07-12 |
| AU726868B2 (en) | 2000-11-23 |
| JPH10165199A (en) | 1998-06-23 |
| DE69728115T2 (en) | 2004-08-26 |
| AU4760297A (en) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2224034C (en) | Mediators useful in an electrochemical biosensor | |
| EP0704535B1 (en) | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | |
| CA2141494C (en) | Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof | |
| Scheller et al. | Second generation biosensors | |
| CA2667295A1 (en) | Transient decay amperometry | |
| Pandey et al. | Ethanol biosensors and electrochemical oxidation of NADH | |
| Razumiene et al. | 4-Ferrocenylphenol as an electron transfer mediator in PQQ-dependent alcohol and glucose dehydrogenase-catalyzed reactions | |
| Tkac et al. | Monitoring of ethanol during fermentation using a microbial biosensor with enhanced selectivity | |
| Murthy et al. | Benzoquinone modified electrode for sensing NADH and ascorbic acid | |
| Amine et al. | Long-term operational stability of a mixed glucose oxidase-redox mediator-carbon paste electrode | |
| Tzang et al. | Voltammetric biosensors for the determination of formate and glucose-6-phosphate based on the measurement of dehydrogenase-generated NADH and NADPH | |
| Mizutani et al. | Amperometric glucose-sensing electrode based on carbon paste containing poly (ethylene glycol)-modified glucose oxidase and cobalt octaethoxyphthalocyanine | |
| Wang et al. | Improved alcohol biosensor based on ruthenium-dispersed carbon paste enzyme electrodes | |
| Jeffries et al. | Evaluation of a thermophile enzyme for a carbon paste amperometric biosensor: L-glutamate dehydrogenase | |
| JP7421268B2 (en) | new mediator | |
| Pandey et al. | Amperometric enzyme sensor for glucose based on graphite paste-modified electrodes | |
| Kulys et al. | Amperometric dertermination of phosphate ions by biosensor | |
| Uchiyama et al. | Immobilization of uricase to gas diffusion carbon felt by electropolymerization of aniline and its application as an enzyme reactor for uric acid sensor | |
| Zahir et al. | Fabrication of directly polymerized 4-vinylpyridine onto a pencil 2B graphite paste electrode for glucose monitoring | |
| Kulys et al. | Recombinant Microdochium nivale carbohydrate oxidase and its application in an amperometric glucose sensor | |
| Yao et al. | Preparation of a carbon paste/alcohol dehydrogenase electrode using polyethylene glycol-modified enzyme and oil-soluble mediator | |
| Yao et al. | Electroanalytical properties of aldehyde biosensors with a hybrid-membrane composed of an enzyme film and a redox Os-polymer film | |
| JP2012026993A (en) | Enzyme electrode and enzyme sensor using enzyme electrode | |
| Arai et al. | Electrochemical characteristics of glucose oxidase immobilized in poly (quinone) redox polymers | |
| Hirano et al. | Novel electron transfer mediators, indoaniline derivatives for amperometric lactate sensor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20121210 |
|
| MKLA | Lapsed |
Effective date: 20121210 |